TRVN Quote, Trading Chart, Trevena Inc.

$ Last:

Change Percent:

$ Open:

$ Previous Close:

$ High:

$ Low:

0 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-01-22	2.15	2.21	2.22	2.12	2,683,993
2021-01-21	2.18	2.16	2.18	2.12	1,586,598
2021-01-20	2.19	2.15	2.2	2.12	2,196,207
2021-01-19	2.19	2.18	2.25	2.14	3,119,217
2021-01-18	2.19	2.12	2.24	2.11	3,661,033
2021-01-15	2.19	2.12	2.24	2.11	3,480,135
2021-01-14	2.22	2.18	2.24	2.16	2,372,629
2021-01-13	2.22	2.2301	2.2387	2.16	2,364,063
2021-01-12	2.21	2.21	2.24	2.15	2,864,215
2021-01-11	2.33	2.18	2.34	2.16	5,115,043
2021-01-08	2.42	2.4	2.47	2.38	2,991,652
2021-01-07	2.24	2.42	2.42	2.24	4,288,837
2021-01-06	2.1731	2.22	2.31	2.17	3,914,795
2021-01-05	2.09	2.16	2.18	2.065	2,261,318
2021-01-04	2.12	2.11	2.15	2.06	3,716,964
2021-01-01	2.15	2.14	2.175	2.08	3,545,270
2020-12-31	2.15	2.14	2.175	2.08	3,421,691
2020-12-30	2.13	2.14	2.2	2.09	2,056,702
2020-12-29	2.2	2.13	2.22	2.1	3,703,524
2020-12-28	2.29	2.2	2.33	2.2	3,473,908

Stock Information

Trevena Inc. Company Name:

TRVN Stock Symbol:

NASDAQ Market:

Trevena Inc. Website:

TRVN Quote, Trading Chart, Trevena Inc.

Get TRVN Alerts

News, Short Squeeze, Breakout and More Instantly...

TRVN - Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate ...
TRVN - Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK(TM) and Announces Anticipated Pipeline Catalysts

-- Build-out of customer-facing team on track for this quarter OLINVYK comprehensive product dossier / health economic model now available to facilitate formulary reviews -- CHESTERBROOK, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a b...
TRVN - Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting

-- P resentations highlight efficacy of TRV045 in animal models of neuropathic pain and epilepsy TRV045 selectively targets the S1P 1 receptor without associated lymphopenia IND filing on track for 1H 2021 -- CHESTERBROOK...